
Company Number
06125301
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
harrington house old mill close, aythorpe roding, dunmow, essex, CM6 1AN
Website
www.worldwithouttb.orgPomanda estimates the enterprise value of WORLD WITHOUT TB at £54.1k based on a Turnover of £135.3k and 0.4x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of WORLD WITHOUT TB at £217 based on an EBITDA of £70 and a 3.08x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of WORLD WITHOUT TB at £59.2k based on Net Assets of £25.2k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
World Without Tb is a live company located in dunmow, CM6 1AN with a Companies House number of 06125301. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2007, it's largest shareholder is unknown. World Without Tb is a established, micro sized company, Pomanda has estimated its turnover at £135.3k with low growth in recent years.
Pomanda's financial health check has awarded World Without Tb a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
7 Weak
Size
annual sales of £135.3k, make it smaller than the average company (£728.4k)
- World Without Tb
£728.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (7.2%)
- World Without Tb
7.2% - Industry AVG
Production
with a gross margin of 22.3%, this company has a higher cost of product (38.6%)
- World Without Tb
38.6% - Industry AVG
Profitability
an operating margin of 0.1% make it less profitable than the average company (5.2%)
- World Without Tb
5.2% - Industry AVG
Employees
with 2 employees, this is below the industry average (18)
- World Without Tb
18 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- World Without Tb
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £67.7k, this is more efficient (£45.8k)
- World Without Tb
£45.8k - Industry AVG
Debtor Days
it gets paid by customers after 70 days, this is later than average (20 days)
- World Without Tb
20 days - Industry AVG
Creditor Days
its suppliers are paid after 3 days, this is quicker than average (18 days)
- World Without Tb
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- World Without Tb
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - World Without Tb
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 3.5%, this is a lower level of debt than the average (22.4%)
3.5% - World Without Tb
22.4% - Industry AVG
World Without Tb's latest turnover from March 2024 is estimated at £135.3 thousand and the company has net assets of £25.2 thousand. According to their latest financial statements, we estimate that World Without Tb has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7,451 | 1,832 | 6,228 | 17,332 | 860 | 2,191 | 2,064 | 4,138 | 3,505 | 2,949 | |||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | -1,234 | 1,450 | 5,066 | 3,547 | -663 | 1,264 | 578 | 3,348 | 2,240 | 1,969 | |||||
Tax | |||||||||||||||
Profit After Tax | -1,234 | 1,450 | 5,066 | 3,547 | -663 | 1,264 | 578 | 3,348 | 2,240 | 1,969 | |||||
Dividends Paid | |||||||||||||||
Retained Profit | -1,234 | 1,450 | 5,066 | 3,547 | -663 | 1,264 | 578 | 3,348 | 2,240 | 1,969 | |||||
Employee Costs | |||||||||||||||
Number Of Employees | |||||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | |||||||||||||||
Stock & work in progress | |||||||||||||||
Trade Debtors | 26,101 | 26,048 | 26,176 | 25,303 | 23,614 | 81 | 577 | ||||||||
Group Debtors | |||||||||||||||
Misc Debtors | |||||||||||||||
Cash | 19,776 | 20,410 | 19,400 | 13,914 | 10,247 | 10,970 | 9,621 | 8,962 | 5,118 | 3,456 | |||||
misc current assets | |||||||||||||||
total current assets | 26,101 | 26,048 | 26,176 | 25,303 | 23,614 | 19,776 | 20,410 | 19,400 | 13,914 | 10,247 | 10,970 | 9,621 | 9,043 | 5,695 | 3,456 |
total assets | 26,101 | 26,048 | 26,176 | 25,303 | 23,614 | 19,776 | 20,410 | 19,400 | 13,914 | 10,247 | 10,970 | 9,621 | 9,043 | 5,695 | 3,456 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 900 | 900 | 1,907 | 1,550 | 900 | 420 | |||||||||
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 400 | 420 | 420 | 300 | 360 | 275 | 275 | 275 | 276 | ||||||
total current liabilities | 900 | 900 | 1,907 | 1,550 | 900 | 1,000 | 400 | 840 | 420 | 300 | 360 | 275 | 275 | 275 | 276 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 900 | 900 | 1,907 | 1,550 | 900 | 1,000 | 400 | 840 | 420 | 300 | 360 | 275 | 275 | 275 | 276 |
net assets | 25,201 | 25,148 | 24,269 | 23,753 | 22,714 | 18,776 | 20,010 | 18,560 | 13,494 | 9,947 | 10,610 | 9,346 | 8,768 | 5,420 | 3,180 |
total shareholders funds | 25,201 | 25,148 | 24,269 | 23,753 | 22,714 | 18,776 | 20,010 | 18,560 | 13,494 | 9,947 | 10,610 | 9,346 | 8,768 | 5,420 | 3,180 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 53 | -128 | 873 | 1,689 | 23,614 | -81 | -496 | 577 | |||||||
Creditors | -1,007 | 357 | 650 | 900 | -420 | 420 | |||||||||
Accruals and Deferred Income | -400 | -20 | 120 | -60 | 85 | -1 | 276 | ||||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 1,211 | ||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -19,776 | -634 | 1,010 | 5,486 | 3,667 | -723 | 1,349 | 659 | 3,844 | 1,662 | 3,456 | ||||
overdraft | |||||||||||||||
change in cash | -19,776 | -634 | 1,010 | 5,486 | 3,667 | -723 | 1,349 | 659 | 3,844 | 1,662 | 3,456 |
Perform a competitor analysis for world without tb by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in CM6 area or any other competitors across 12 key performance metrics.
WORLD WITHOUT TB group structure
World Without Tb has no subsidiary companies.
Ultimate parent company
WORLD WITHOUT TB
06125301
World Without Tb currently has 8 directors. The longest serving directors include Mr Rafiq Rattansi (Feb 2007) and Dr Christopher Brown (Oct 2010).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Rafiq Rattansi | 76 years | Feb 2007 | - | Director | |
Dr Christopher Brown | United Kingdom | 69 years | Oct 2010 | - | Director |
Mr Giles Bailey | Scotland | 59 years | Dec 2012 | - | Director |
Mr Christopher Wakley | England | 42 years | Oct 2015 | - | Director |
Mr Matthew Powell | Great Britain | 37 years | Apr 2018 | - | Director |
Miss Rehana Rattansi | England | 74 years | Apr 2021 | - | Director |
Dr Arif Shivji | England | 56 years | Sep 2021 | - | Director |
Dr Altaf Moledina | England | 50 years | Mar 2023 | - | Director |
P&L
March 2024turnover
135.3k
+9%
operating profit
70.7
0%
gross margin
22.3%
+3.95%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
25.2k
0%
total assets
26.1k
0%
cash
0
0%
net assets
Total assets minus all liabilities
company number
06125301
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
February 2007
age
18
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
world without tb limited (March 2007)
accountant
-
auditor
-
address
harrington house old mill close, aythorpe roding, dunmow, essex, CM6 1AN
Bank
HSBC BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to world without tb.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WORLD WITHOUT TB. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|